Annotation Detail for RAB11FIP5
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04144 | Endocytosis |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C408982 |
CPG-oligonucleotide |
CPG-oligonucleotide results in increased expression of RAB11FIP5 protein | increases expression | 17727805
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of RAB11FIP5 mRNA | increases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of RAB11FIP5 mRNA | increases expression | 18042831
|
C041786 |
palm oil |
palm oil results in increased expression of RAB11FIP5 mRNA | increases expression | 18042831
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of RAB11FIP5 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.02 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.30 | 19490988 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.85 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.86 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
4.37 | 15238619 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18384058 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 17688650 17507914 18177632 18316065 16609825 20603192 15238991 18940202 19460635 17157402 18558336 19232924 18775368 18396377 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.23 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.61 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.25 | 20435547 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.81 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.17 | 19486331 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 8888407 16575769 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.25 | 1733752 19641884 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.70 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.45 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.64 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.53 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.09 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.91 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.78 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.60 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.39 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
15.39 | 18296743 19004024 17967931 19551842 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
15.39 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.57 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
10.35 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
10.35 | 18296743 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.76 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.96 | 15720958 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.97 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
4.02 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.20 | 10903974 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.59 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.32 | 18457598 11836018 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.52 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.04 | 12371664 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
3.05 | 18296743 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.87 | 17228818 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.40 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.44 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.40 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.33 | 17596541 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.61 | 18481113 19348381 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.34 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.35 | 18457598 20518802 17217161 11836018 16723640 21332399 20132043 18674790 19632207 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.55 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.37 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.15 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.32 | 16882103 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.96 | 15475178 11738929 1511512 16876388 11044598 3137016 17978042 14763951 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.06 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.15 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.85 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.06 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.13 | 8888407 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.59 | 1336536 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
4.06 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.05 | 17120751 |